Assessing the control of the disease on current treatments available in Romania for hereditary angioedema patients

Abstract

Background: Acute treatment must be permanently accessible for every patient diagnosed with hereditary angioedema (HAE). In many cases this type of therapy does not provide/offer sufficient control of the disease, so long-term prophylaxis (LTP) is recommended. In the case of regular and prolonged/extended administration of drugs, the route of administration is essential. The aim of the investigation was to assess the control of HAE among patients in Romania receiving the available medications, while also examining potential correlations within the outcomes.

Keywords

• angioedema
• hereditary angioedema
• quality of life
• on-demand
• long-term prophylaxis